Home
Loading

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

Get in touch

  • Contact

  • Request a demo

  • Request data updates

  • Add a company

Research

  • Companies

  • Investors

  • People

aVenture

  • Sitemap

  • Feature requests

Member

Backed by

© aVenture Investment Company, 2026. All rights reserved.

San Francisco, CA, USA

Privacy Policy

aVenture Investment Company ("aVenture") is an independent research platform providing detailed analysis and data on startups, venture capital investments, and key industry individuals. It is not a registered investment adviser, broker-dealer, or investment advisor and does not provide investment advice or recommendations. The data provided by aVenture does not constitute recommendations or advice, whether by methodology, analysis, AI-generated content, or a statement written by a staff member of aVenture.

aVenture is not affiliated with any of the people, companies, organizations, government agencies, regulatory bodies, or investment funds we provide coverage for on this site unless explicitly stated otherwise. Users assume full responsibility for decisions made based on information obtained from this platform. Links to external websites do not imply endorsement or affiliation with aVenture. Any links that provide the ability to invest in a primary or secondary transaction in a company are for convenience only and do not constitute solicitations or offers to buy or sell an investment. Investors should exercise heightened precaution and due diligence when investing in private companies, especially those not independently audited.

While we strive to provide valuable insights with objectivity and professional diligence, we cannot guarantee the accuracy of the information provided on our platform. Before making any investment decisions, you should verify the accuracy of all pertinent details for your decision. To the fullest extent permitted by law, aVenture shall not be liable for any direct, indirect, incidental, consequential, or financial damages arising from use of this site, whether by consumers of its contents directly or by persons or organizations covered by our research, even if we are advised of the possibility. Our best-efforts processes and correction request forms do not create a warranty or duty of care.

Profiles on this platform may include content generated in part by large language models (LLMs, artificial intelligence) that aggregate publicly available sources (e.g., SEC EDGAR, public filings, press releases). Source attribution is provided where known; always verify statements and claims here against original sources before relying on any data. Content on our site may contain inaccuracies, omissions, or what are commonly called 'hallucinations' if generated in part or in full by AI / LLMs. The risk can also exist even when content is written by a human, as internal and third-party sources may also have inaccuracies for the same or different reasons. While we randomly audit a proportion of content, this is not exhaustive.

We recommend that an independent auditor be hired to verify the accuracy of the information before relying on it for any sensitive decisions. By accessing this platform, you agree not to rely solely on any information generated by AI, aggregated, or sourced or written otherwise on this site, for investment, financial, or other decisions. aVenture assumes no responsibility for inaccuracies, omissions, or hallucinations. You must independently verify all data from primary sources. Use of this platform constitutes your waiver of claims for reliance-based damages, including negligent misrepresentation. To report an error, request a correction, or dispute information about a company or individual, contact us via our request data updates form.

Loading homepage
Loading
Loading
Loading
Home›
Research›
Investment Firms›
Sequoia China
AddedFeb 13, 2024
UpdatedJul 16, 2026
Sequoia China

Sequoia China

Operating

Sequoia Capital China: A fintech-focused VC firm with a diverse portfolio of high-return investments.

Location
Beijing, Beijing, CN
Founded
2005
Firm
Analysis
Compare
Portfolio
Employees

Investments

Generation Lab
Generation Lab

Rounds

1

Pre-SeedJanuary 2024
Petlibro
Petlibro

Total Raised

$24M

Rounds

2

Series B$14MDecember 2023
Spear Bio
Spear Bio

Rounds

1

SeedNovember 2023
dappOS
dappOS

Rounds

2

SeedJuly 2023
Noah Medical
Noah Medical

Total Raised

$150M

Rounds

1

Series B$150MApril 2023
zkPass
zkPass

Total Raised

$2.5M

Rounds

5

Seed$2.5MApril 2023
Scroll
Scroll

Total Raised

$80M

Rounds

3

Series Unknown$50MMarch 2023
Taiko Labs
Taiko Labs

Total Raised

$22M

Rounds

3

Seed$10MSeptember 2022
Enpower Greentech
Enpower Greentech

Total Raised

$35M

Rounds

1

Series A$35MJune 2022
Frontera Therapeutics
Frontera Therapeutics

Total Raised

$160M

Rounds

1

Series B$160MJune 2022
EthSign
EthSign

Total Raised

$12.7M

Rounds

4

Seed$12MJune 2022
NuProbe
NuProbe

Total Raised

$103M

Rounds

4

Series B$50MJune 2022
Afriex
Afriex
Angel

Total Raised

$11.4M

Rounds

5

Series A$10MApril 2022
Metis Therapeutics
Metis Therapeutics

Total Raised

$261M

Rounds

3

Series B$75MApril 2022
Series A$86MDecember 2021
Miracle Miles tech
Miracle Miles tech

Total Raised

$100M

Rounds

1

Series A$100MMarch 2022
Slope Finance
Slope Finance

Total Raised

$10.3M

Rounds

3

Series A$8MFebruary 2022
Animoca Brands
Animoca Brands

Total Raised

$860.9M

Rounds

29

Late Stage Private$358.9MJanuary 2022
Series Unknown$65MOctober 2021
Treelab
Treelab

Total Raised

$23.9M

Rounds

4

Series ADecember 2021
ABclonal
ABclonal

Total Raised

$1.3B

Rounds

2

Series D$1.2BDecember 2021
Vesta Home
Vesta Home

Rounds

3

Series AOctober 2021
Nreal
Nreal

Total Raised

$306M

Rounds

9

Series C$100MSeptember 2021
Outer
Outer

Total Raised

$65M

Rounds

6

Series B$50MSeptember 2021
XtalPi
XtalPi
Public

Total Raised

$793.5M

Rounds

10

Series D$400MAugust 2021